LSE:BVXP
Bioventix PLC · LSE · Healthcare · GBP · FY for 2026
Figures on this page computed 2026-11-07 15:12 UTC
Last close
n/aGBp
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
13.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
- Computed from the filing for 2026
121.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
58.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
61.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
0.001Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
7.6%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
Growth is the furthest below its sector's middle: 0.34 against 0.47 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.17x
Its own average over 10 years, 11.1M.
- Profit1.09x
Its own average over 10 years, 7.0M.
- Free cash flow1.18x
Its own average over 10 years, 6.8M.
- Debt1.00x
Its own average over 1 year, 11.0K.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 1.18 times.
The filed years, as a table
10Each line is 100 at 2017-06-30, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-06-30 | 100.0 | 100.0 | 100.0 |
| 2018-06-30 | 120.8 | 115.1 | 100.6 |
| 2019-06-30 | 128.2 | 119.1 | 100.6 |
| 2020-06-30 | 142.3 | 146.3 | 100.5 |
| 2021-06-30 | 150.9 | 136.8 | 101.2 |
| 2022-06-30 | 161.7 | 155.9 | 101.2 |
| 2023-06-30 | 176.9 | 170.1 | 101.8 |
| 2024-06-30 | 187.8 | 164.5 | 101.9 |
| 2025-06-30 | 181.0 | 154.1 | 101.8 |
| 2026-06-30 | 179.0 | 154.7 | 102.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- GBP
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- GBP
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- GBP
Figures behind the shape
Growth
3.5%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate3.5%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
Five-year EPS growth rate2.5%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
One-year change in net income0.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
Returns on capital
121.1%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capital121.1%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity66.7%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets59.4%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
91.0%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin91.0%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin75.0%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin58.7%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin61.9%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
13.4xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings13.4x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
- Computed from the filing for 2026
Price to book9.1x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA10.0x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio8.0x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.001safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equity0.001
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio8.53
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage69524.2x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Score49.51
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
7.6%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yield7.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
Payout ratio102.9%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio1.0x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- GBp
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.